Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar rwpaules (92.05) Submitted: 2/7/2012 1:07:19 PM : Underperform Start Price: $3.19 OREX Score: -8.50

Shorting the recent pop, which seems to have petered out.

Featured Broker Partners


Advertisement